Summary Gallium-67 is a radionuclide that accumulates in haematological malignancies and is used for diagnostic purposes. Uptake of 67Ga into the cell occurs via the transferrin receptor, which is differentially expressed during the various cell cycle phases. With the aim of selectively increasing 67Ga uptake, we studied whether the transferrin receptor (TfR) expression could be modulated in the U937 and U715 lymphoma cell lines by cytostatic drugs inducing cell cycle phase accumulation. We tested clinically relevant drugs such as 1-f-D-arabinofuranosylcytosine (Ara-C), hydroxyurea and methotrexate. Cytotoxicity was determined by testing the clonogenic capacity of the lymphoma cell lines. All three drugs induced an increase in S-phase content, TfR expression and 67Ga uptake in U937 and U715 single cells. The combinations of drugs and 67Ga resulted in an additive effect on the clonogenic capacity. In U937 spheroids, cultured by the fibrin clot technique, we found an accumulation in the S-phase too as well as an increase of the transferrin receptor expression after Ara-C preincubation. As in single cells 67Ga uptake was increased without synergistic effects on the clonogenic capacity. In conclusion, priming with drugs induces increased transferrin receptor expression and 67Ga uptake. Inhibition of clonogenic capacity was additive rather than synergistic.
Gallium-67 citrate (67Ga) is an established diagnostic tracer which selectively accumulates in malignancies such as melanoma, lung cancer and malignant lymphoma (Manfredi and Weiss, 1978) . Based on the particular emission spectrum of 67Ga (photons and low-energy electrons) the possibility has been considered that this radionuclide might have a therapeutic potential as well. In previous studies we have described the uptake and radiotoxicity of 67Ga in haematological cell lines in vitro Van LeeuwenStok et al., 1993) and in leukaemic blast cells ex vivo (Jonkhoff et al., 1995a) . Furthermore, phase I/II trials with 67Ga in patients with acute leukaemia and lymphoma were performed and some short-lived responses have been noted Jonkhoff et al., 1995b) . Like iron, 67Ga binds to the transport molecule transferrin and enters the cells via the transferrin receptor (Harris and Sephton, 1977; Van Leeuwen-Stok et al., 1993) . The iron requirements of the cell and the expression of the transferrin receptor varies during the cell cycle, being highest during the S-and G2M-phases (E Pelosi-Testa et al., 1986, unpublished observations) . Previously, while using iron depletion, we have shown a positive relation between the transferrin receptor expression and 67Ga uptake in the human lymphoid cell line U715 (Van Leeuwen-Stok et al., 1993) . Therefore, increasing 67Ga uptake in cells may be affected not only by increasing the 67Ga concentration in the medium surrounding the cells but, more selectively, by increasing the transferrin receptor expression.
Various agents are able to increase transferrin receptor expression, among which are desferrioxamine (Hedley et al., 1985) , phorbol esters (Neckers, 1991) and anti-cancer drugs.
For example, incubation with 1-fl-D-arabinofuranosylcytosine (Ara-C) induces an increase in the number of transferrin receptors on oropharyngeal carcinoma KB cells (Caraglia et al., 1993) . Furthermore, hydroxyurea treatment increased transferrin receptor expression in human T-cell leukaemia cells CCRF-CEM (Hedley et al., 1985) .
In this in vitro study we examined the effects of Ara-C. Flow cytometric DNA analysis Nuclei were prepared for flow cytometric DNA analysis with propidium iodide (PI) according to the method of Vindel0v and Christensen (1994) . Nuclei (20 000 events) were analysed using the FACScan (Becton Dickinson, Mountain View, CA). Cell cycle analysis was performed using CellFit DNA analysis software (Becton Dickinson). All data are presented as the mean of n experiments (n is indicated in Table I ). Bars indicate the standard error of the mean. In Figures 1-4 , an independent Student's t test (cx = 0.05) has been used. The hypothesis tested was: the difference in means=0 (no statistically significant difference).
Results

Preincubation with cytostatic drugs
For most concentrations of drugs tested, 5 days of preincubation was optimal for up-regulation of the TfR. The concentrations found to inhibit cell proliferation by 50%
at maximum are shown in Table I . It should be noted that these concentrations do not necessarily cause a maximal increase of the TfR expression. For further experiments drug concentrations marked with an asterisk in Table I were used, unless otherwise indicated.
Cell cycle effect of drug preincubation In Figure 1 the effect of 5 days' preincubation on cell cycle distribution in the two cell lines is shown. Preincubation with Ara-C, hydroxyurea and methotrexate induced increases in Sphase cells in both U937 and U715 cells, which represent statistically significant differences from control experiments for all drugs used except for the combination U715 and methotrexate ( Figure 1 ). Furthermore, in U937 cells a tendency towards an increase in the percentage of G2M-phase cells was seen, which was significant for hydroxyurea.
Transferrin receptor expression and 67Ga uptake All drugs caused an increase of the TfR expression (FI) after 5 days of preincubation in both cell lines, although a statistically significant difference was not reached in all cases (Figure 2a and b). These increased TfR expressions were in qualitative concordance with the 67Ga uptake shown in the right columns of Figure 2 . Here also a statistically significant difference was not reached for all cases. Although increases of the TfR expression and 67Ga uptake parallel each other, there are discrepancies between the extent of both. This is probably Table I ). *Indicates a statistically significant increase (P<0.05).
Control ME; Ara-C M; hydroxyurea and methotrexate mdue to the relatively small increase of TfR expression and 67Ga uptake which may become clear from Figure 3 . Figure 3 shows that further increase of the Ara-C concentrations in U715 cells up to cytotoxicity levels that exceeded 50% proliferation inhibition (0.005 and 0.01 jg ml-') led to a further increase of transferrin receptor expression, which resulted in a relatively large increase of 67Ga uptake in these cells. Thus, there is a good parallel between increase of TfR expression and 67Ga uptake but these are relatively small at the drug concentrations that can be used without causing extreme proliferation inhibition.
Clonogenic capacity Figure 4 shows the clonogenic capacity after 67Ga treatment in cells preincubated with or without drugs. The open bars indicate the expected clonogenic capacity (Exp), which represents the sum of the individual effects of 67Ga and drug. This figure shows that 67Ga incubation after Ara-C preincubation in both cell lines resulted in a higher decrease of the clonogenic capacity than expected (open bars in the second columns). However, the clonogenic capacity than expected (open bars in the second columns). However, the clonogenic capacity after 67Ga incubation both with or without Ara-C preincubation is equal (compare hatched bars in first and second columns). This may be caused by stimulation of the clonogenic capacity of the residual cells by Ara-C alone, although this stimulation is not statistically significant from the control cells. Since this stimulation by Ara-C itself makes the results difficult to interpret, we also used a higher concentration of Ara-C despite the pronounced proliferation inhibition. In U715 cells 0.01 Mg ml-' Ara-C led to an inhibition of the clonogenic capacity of 50%. When 67Ga and Ara-C were used together an 86% inhibition was found (data not shown). The expected value of the combination would be 95% inhibition (50% for Ara-C and 45% for 67Ga) showing not more than an additive effect. 67Ga incubation after hydroxyurea and methotrexate preincubation resulted in a lower or equal clonogenic capacity compared with the expected values (third and fourth columns of Figure  4 ).
Effect of Ara-C preincubation in multicellular spheroids
In order to see whether drug preincubation can be of benefit for 67Ga treatment in a micrometastasis model, we used multicellular spheroids (Van Leeuwen-Stok et al., 1996) . Since in the single cell experiments similar effects were found with the three drugs in both cell lines, we have chosen to use one particular combination, Ara-C in U937 spheroids. In Table I the Ara-C concentration used and the effect of "Ga uptake accumulation in the S-and G2M-phase. The TfR expression could be up-regulated by a factor of 2 (Figure 5b , left columns), but this did not result in a similar pronounced increase of the 67Ga uptake, which is shown in the right columns of Figure 5b . 67Ga incubation in multicellular spheroids for 1 day resulted in 35% inhibition of the clonogenic capacity in U937 spheroid-derived cells ( Figure  5c ). Ara-C preincubation did not result in a higher inhibition of the clonogenic capacity of the remaining cells than could be expected from the individual effects of 67Ga and Ara-C in spheroid-derived cells (Figure 5c ).
Discussion
In former studies we have shown a direct relation between transferrin receptor expression after iron depletion and 67Ga uptake (Van Leeuwen-Stok et al., 1993) . Therefore, one way to increase 67Ga uptake might be to increase transferrin receptor expression. There are various ways to increase the transferrin receptor expression on cultured cells such as iron chelation by desferrioxamine (Akin and Sonnenfeld, 1993) (n = 3 -8, see Table I In this study we have shown that Ara-C, hydroxyurea and methotrexate induced an accumulation in the S-phase of the cell cycle in U937 and U715 cells. Since the ironrequiring DNA synthesis takes place in the S-phase of the cell cycle it might be expected that the transferrin receptor expression increases when cells are accumulating in the Sphase. Indeed, the transferrin receptor expression was upregulated by 5 days' preincubation with Ara-C, hydroxyurea and methotrexate and these increases are more pronounced than those found previously after 1 day of incubation (unpublished observations). However, the increases were less than expected. For hydroxyurea this may be explained by its mechanism of action. Hydroxyurea inhibits the activity of the M2 subunit of the enzyme ribonucleotide reductase (Chitambar et al., 1988) . Since the iron requirements of the cell appear to be directly related to increased activity of the M2 subunit of ribonucleotide reductase (Eriksson et al., 1984) , inhibition of the M2 subunit by hydroxyurea may decrease the iron requirements. Since also the transferrin receptor expression is related to the iron requirements (Pelosi-Testa et al., 1986) , the transferrin receptor expression and consequently the 67Ga uptake might be less upregulated than might be expected from the increased Sphase accumulation. For Ara-C no apparent explanation is available. The effect of the drug methotrexate was studied, since in a previous study we have found that after preincubation an antagonist effect on proliferation to 67Ga occurred, which hypothetically might be due to a decreased transferrin receptor expression (unpublished results). However, in this study, while using about the same methotrexate concentrations, we found an increase of transferrin receptor expression and 67Ga uptake after preincubation. This did not result in synergistic effects on the clonogenic capacity of remaining cells. Therefore, decreased transferrin receptor expression was not the cause of the antagonistic effect seen on proliferation (unpublished results) and clonogenic capacity (this study). In addition, relatively flat doseresponse curves might contribute to the disappointing effects on the clonogenic capacity, e.g. increasing the uptake of 67Ga three times by a higher external 67Ga concentration resulted in an increase of toxicity of only 20% (unpublished results).
Although in this study the increases in TfR expression were associated with higher 67Ga uptake, there are discrepancies between the extent of both increases. This is probably partly a result of the relatively low increases of the TfR expression. The presence of insulin in our culture system, a growth factor essential for cell proliferation, could have induced up-regulation of the transferrin receptor (Akin and Sonnenfeld, 1993) . Therefore, the control cells in our culture system may already be primed for transferrin receptor expression resulting in a less pronounced effect of the cytostatic drugs. Nevertheless, when using a series of Ara-C concentrations a dose-dependent increase of TfR expression and 67Ga uptake could be demonstrated clearly suggesting the potency of this approach.
To investigate whether the treatment schedules used can be of benefit in micrometastasis we used multicellular tumour spheroids. The transferrin receptor expression could be upregulated by a factor of 2 by Ara-C in multicellular spheroids. However, this increases the 67Ga uptake by a factor of 1.4 with only a minor effect on the clonogenic capacity. This might be related to the barrier for 67Ga penetration present in the spheroid (Van Leeuwen-Stok et al., 1996) as well as to the flat dose-response curves.
Higher drug concentrations may lead to higher TfR expression and 67Ga uptake which may induce a significant inhibition of the clonogenic capacity. In this study we have chosen drug concentrations which induce suboptimal proliferation inhibition and cell death to prevent too much selection in the cell population by preincubation with the drug. Steel (1994) proposed that the benefits of priming with We have shown that the use of a combined treatment with low doses of different agents results in a cytotoxic effect on the tumour that is in most cases higher or equal to the sum of individual toxicities. If these results can be extrapolated to the in vivo situation, it will therefore depend on the relative side-effects of both modalities in the patient whether combination treatment is of clinical advantage.
We may conclude that it is possible to induce increase of transferrin receptor expression and 67Ga uptake by Ara-C, hydroxyurea and methotrexate which results in an additive effect on the clonogenic capacity in lymphoma cells in vitro when combined with 67Ga. Such a combination treatment may be of benefit for treatment of malignant lymphoma depending on the relative side-effects.
